Please login to the form below

Not currently logged in
Email:
Password:

Gocovri

This page shows the latest Gocovri news and features for those working in and with pharma, biotech and healthcare.

FDA approves new indication for Adamas’ Gocovri in Parkinson’s disease

FDA approves new indication for Adamas’ Gocovri in Parkinson’s disease

In two phase 3 clinical studies, Gocovri treatment was shown to significantly reduce both OFF time and dyskinesia. ... Gocovri is now the first and only medication approved to treat both OFF and dyskinesia motor complications in Parkinson’s disease,”

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
W2O Group

W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...

Latest intelligence

01 PME-APR21 Cover.jpg
Virtual congresses: video thrilled the cardio tsar
Chris Ross explores the key learnings from a year of virtual congresses...
When Will We Be Back To Normal?
The definitive question of 2021, whether you’re a homeschooling parent, a homebound professional, a wanderer with nowhere to go… or all three at once....
How to tell your healthcare story.
Healthcare research is not a simple story and the people in charge of those moments need to be careful about the story that they tell....

Infographics